ClinConnect ClinConnect Logo
Search / Trial NCT05923606

Modulation of Brain Oscillations Underlying Working Memory

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jun 27, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Working Memory Attention Theta Oscillations Transcranial Alternating Current Stimulation

ClinConnect Summary

This clinical trial is looking at how a new technique called transcranial alternating current stimulation (tACS) can help improve working memory, which is our ability to hold and use information in our minds for short periods. The study will involve applying gentle electrical currents to the scalp while measuring brain activity with a method called electroencephalography (EEG). This approach is noninvasive, meaning it doesn't require surgery or significant discomfort. Researchers hope to understand better how brain rhythms affect our memory.

To participate, you need to be between the ages of 65 and 74 and able to understand and provide consent in English. You won't be eligible if you have a history of neurological or psychiatric disorders, are currently taking certain medications, or have specific medical devices like pacemakers. If you join the study, you can expect a safe and supportive environment where your brain activity will be monitored as you engage in memory tasks. This trial is currently recruiting participants, and it's an exciting opportunity to contribute to research that could lead to new ways of enhancing memory function.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Able to provide informed consent
  • Fluent in English.
  • Exclusion Criteria:
  • History of a neurological/psychiatric disorder
  • Current use of psychotropic medications
  • Current use of substances and drugs that were shown to affect tES (transcranial electrical stimulation) efficacy (dopamine altering drugs, nicotine, NMDA (N-methyl-D-aspartate) antagonists/agonists, sodium/calcium channel blockers, norepinephrine reuptake inhibitors, GABAergic modulators and selective serotonin reuptake inhibitors)
  • Contraindications for tACS (e.g., history of seizures, metallic implants in the head or neck, implanted brain stimulators, vagus nerve stimulators, pacemakers, pregnancy)

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Charlestown, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Hamdi Eryilmaz, Ph.D.

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported